Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,411 public trials 1,032 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Active, Not Recruiting

Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells

NCT03690011

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia

NCT04075292

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: Research Site Beijing, China

Research Site Changchun, China

Research Site Changsha, China

Research Site Changzhou, China

View all 46 locations

View Trial Details

Active, Not Recruiting

A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

NCT05386576

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia

NCT02427451

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

NCT01430390

Conditions: Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS

NCT04668885

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Active, Not Recruiting

Encorafenib Plus Binimetinib for People With BRAF V600 Mutated Relapsed/Refractory HCL

NCT04324112

Conditions: Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Characterizing Sleep Among Long-term Survivors of Childhood Cancer

NCT05480904

Conditions: ALL, Adult, CNS Tumor, Central Nervous System Neoplasms, +15 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia

NCT04505254

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia

NCT04214249

Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Post Cytotoxic Therapy, +8 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

Yale University New Haven, Connecticut, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Leukemia

Leukemia trial results

Related conditions